Dual Growth Hormone Axis Research Peptide Blend – For Laboratory Research Use Only

CJC-1295 (No DAC), also known as Modified GRF (1-29), and Ipamorelin are two synthetic research peptides commonly studied together due to their complementary mechanisms of action. CJC-1295 (No DAC) is a growth hormone-releasing hormone (GHRH) analogue, while Ipamorelin is a selective growth hormone secretagogue that targets the ghrelin receptor. Researchers investigate this combination because the two peptides activate different pathways involved in endogenous growth hormone release. This is a vendor-defined blend rather than a single molecule; published evidence primarily exists for the individual component peptides rather than for the combination itself.

This product is not a food, drug, cosmetic, or dietary supplement, and has not been evaluated or approved by the U.S. Food and Drug Administration (FDA) or any other regulatory body for any use. It is not intended for human or veterinary use, diagnosis, treatment, cure, or prevention of any disease.

Product Specifications
-Peptide Blend: CJC-1295 (No DAC) + Ipamorelin
-Strength: 10mg / 10mg (20mg Total)
-Appearance: Lyophilized powder
-Purity: ≥99% (HPLC Tested)
-Storage: Refrigerate after receipt. For extended storage, keep frozen until reconstitution.
-Grade: Research Grade
-Quality Testing: Identity and purity verified for every production batch. COA available on request.

By purchasing, the buyer confirms they are a qualified researcher or institution and assumes full responsibility for legal and appropriate handling of this product in accordance with applicable local, state, and federal regulations. Not for human consumption.